(redirected from synthetic cannabinoid)
Also found in: Medical, Encyclopedia.


Any of various organic substances, such as THC, found in cannabis.


(Chemistry) any of the narcotic chemical substances found in cannabin


(kəˈnæb əˌnɔɪd, ˈkæn ə bə-)

any of the chemical compounds that are the active principles of marijuana.
[1965–70; cannabin a hemp derivative (see cannabis, -in1) + -oid]


adj & n cannabinoide m; synthetic — cannabinoide sintético
References in periodicals archive ?
Black Mamba is classed as a synthetic cannabinoid, which are drugs which produce a reaction similar to the effects of cannabis.
com, a division of SECON, has demonstrated that the new process can identify many of the new synthetic cannabinoid compounds being sold on the street today, making it highly successful in detecting the presence of the drug as compared to previous drug screening protocols.
Acute kidney injury associated with synthetic cannabinoid use--multiple states, 2012.
poison centers reporting adverse health effects or concerns about possible adverse health effects related to synthetic cannabinoid use soared 330% from 349 in January 2015 to 1,501 in April 2015, newly published data from the Centers for Disease and Control and Prevention show.
Summary: News that two university students in the United Kingdom were recently rushed to hospital after using a synthetic cannabinoid highlights a worrying trend.
A synthetic cannabinoid, or spice (left), can be rolled and smoked like marijuana, but may be a riskier choice, sources: u.
ySTANBUL (CyHAN)- A panel discussion on use of illegal narcotics, particularly bonzai, a synthetic cannabinoid, the use of which is 17 times greater than it was three years ago in Turkey, will be held on Nov.
Synthetic cannabinoid products are made of chemicals that are sprayed onto plant material.
When one synthetic cannabinoid becomes a controlled substance, a slight structural modification is made to produce a new synthetic cannabinoid to evade legislation.
Myocardial infarction associated with use of the synthetic cannabinoid K2.
Spice, K2, and other brands contain one or more synthetic cannabinoid compounds, which were originally developed by research chemists to facilitate study of cannabinoid receptor pharmacology.

Full browser ?